0001354457-18-000042.txt : 20180227
0001354457-18-000042.hdr.sgml : 20180227
20180227101941
ACCESSION NUMBER: 0001354457-18-000042
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20180227
DATE AS OF CHANGE: 20180227
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: DEXTERA SURGICAL INC
CENTRAL INDEX KEY: 0001178104
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 943287832
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51772
BUSINESS ADDRESS:
STREET 1: 900 SAGINAW DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-364-9975
MAIL ADDRESS:
STREET 1: 900 SAGINAW DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
FORMER COMPANY:
FORMER CONFORMED NAME: CARDICA INC
DATE OF NAME CHANGE: 20020719
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: The Nasdaq Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: One Liberty Plaza
CITY: New York
STATE: NY
ZIP: 10006
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: Office of General Counsel
STREET 2: 805 King Farm Blvd.
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
25-NSE
1
primary_doc.xml
X0203
0001354457
The Nasdaq Stock Market LLC
0001178104
DEXTERA SURGICAL INC
000-51772
900 Saginaw Drive
Redwood City
CA
CALIFORNIA
94063
650 364-9975
Common Stock
17 CFR 240.12d2-2(b)
Amy Horton
Hearings Advisor
2018-02-27
EX-99.25
2
dxtrdelistreason.txt
Delisting Determination,The Nasdaq Stock Market, LLC,
February 27, 2018, Dextera Surgical Inc. The Nasdaq
Stock Market, Inc. (the Exchange) has determined to remove
from listing the common stock of Dextera Surgical Inc.
(the Company), effective at the opening of the trading
session on March 9, 2018. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rule 5550(b)(1).
The Company was notified of the Staffs determination on
October 17, 2017. The Company appealed the determination
to a Hearing Panel. Upon review of the information provided
by the Company, the Panel issued a decision dated
December 11, 2017 denying the Company continued listing
and notified the Company that trading in the Companys
securities would be suspended on December 13, 2017.
The Company did not request a review of the Panels decision
by the Nasdaq Listing and Hearing Review Council. The
Listing Council did not call the matter for review.
The Panels Determination to delist the Company
became final on January 25, 2018.